RNAZ TRANSCODE THERAPEUTICS INC Capital Structure Changes 8-K Filing 2024 - Stock Split Announcement Transcode Therapeutics, Inc. announced a 1-for-33 reverse stock split effective December 4, 2024, reducing its outstanding shares to approximately 696,233, while maintaining the same par value per share.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC